Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Coursera Inc (COUR) vs Cassava Sciences Inc (FLNA) Price & Performance

Coursera IncTrade
Cassava Sciences IncTrade

Price performance (Past 24H)

Key statistics

Coursera Inc vs Cassava Sciences Inc — how do they compare? Coursera Inc trades at $5.69 (market cap $1.50B), while Cassava Sciences Inc trades at $0.97 (market cap $47.75M). The key difference: Coursera Inc is far larger — about 31.4× Cassava Sciences Inc's market cap. Which is the better fit depends on your goals.

COURFLNA
Market Cap
$1.50B$47.75M
Sector
Consumer StaplesHealth
52-Week High
$12.20$4.64
52-Week Low
$5.09$0.87
Enterprise Value
$759.54M-$34.93M

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Coursera Inc

COUR trades at $5.76, down 0.86% today, with a neutral technical signal. Revenue grew to $757.5M in 2025, but net income remains negative at -$51M. The company recently beat Q2 2026 EPS estimates at $0.17 versus $0.10 expected. Positive cash flow from operations of $108.7M in 2025 supports liquidity, while a $100M investment in LearnVector highlights strategic AI focus.

Outlook is mixed: analyst consensus is bullish with a $7.70 price target (34% upside), but persistent losses and competitive pressures pose risks. The stock offers growth potential if profitability improves, yet high SG&A costs and integration challenges from the Udemy acquisition require monitoring.

Cassava Sciences Inc

FLNA trades at $0.9973, up 0.23% with a bearish technical signal despite recent earnings beats. The company shows negative profitability with ROE at -55.79% and ROA at -35.34%, though cash burn improved from -$33M to -$30M projected for 2026. Analyst consensus is strongly bullish with 8 buy ratings versus 4 hold ratings.

The outlook remains challenging due to persistent losses and negative cash flow, but analyst optimism and continued progress in TSC-related epilepsy therapies provide potential catalysts. Key risks include execution challenges in clinical development and the company's ability to secure additional funding.

Returns comparison

Trailing returns across standard periods

About Coursera Inc

Coursera Inc is a global online learning platform that offers anyone, anywhere access to online courses and degrees from world-class universities and companies. It combines content, data, and technology into a single, unified platform that is customizable and extensible to both individual learners and institutions. The platform will contain a catalog of high-quality content and credentials, content developed by leading university and industry partners, data and machine learning drive personalized Learning, effective marketing, and skills Benchmarking and others.

Read more on COUR

About Cassava Sciences Inc

Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease

Read more on FLNA